Please assess the completion status of the following clinical trial:

Trial Title: Fibromyalgia Health Outcome Study on Cost of Treatments

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Meet criteria for fibromyalgia (FM) in the opinion of the investigator~* Must be prescribed a 'new' treatment for FM~* Male and female participants at least 18 years of age~* Willing to complete the Informed Consent Document (ICD) and any other required forms to be eligible for study participation~* Currently under the care of the participating physician~* Cognitively able to understand and complete participant self-rated scales in English or Spanish via computer-assisted telephone interview (CATI)~* Available for 12 months to participate in the study~Exclusion Criteria:~* Are investigator site personnel directly affiliated with the study and/or their immediate families. Immediate family is defined as a spouse, parent, child, or sibling, whether biological or legally adopted~* Are Lilly employees~* Are Terminally ill~* Currently participating in other research studies or if beginning a research study while participating in this study~* Unable to respond via telephone for CATI~* Incompetent for interview as deemed by the participating physician~* Unwilling to provide written ICD or other required forms to participate in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fibromyalgia (FM) Participants (Type: None): FM participants starting any new pharmacologic FM agent.

Based on this trial design, predict the completion outcome and termination type (if applicable).